Lexology June 5, 2024
DLA Piper

Welcome to FDA Regulatory News and Trends, designed to help you identify significant legal developments and navigate the evolving business, legal, and regulatory world.

CDRH finalizes guidance addressing device remanufacturing and servicing.

  • On May 9, 2024, the FDA Center for Devices and Radiological Health (CDRH) released a guidance document entitled, “Remanufacturing of Medical Devices.” This guidance aims to distinguish the types of activities that qualify as servicing rather than remanufacturing (which involves additional regulatory responsibilities).
  • FDA defines remanufacture as follows: “Process, condition, renovate, repackage, restore, or any other act done to a finished device that significantly changes the finished device’s performance or safety specifications, or intended use.” Since these remanufacturing activities significantly change the device’s performance or safety specifications,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: FDA, Govt Agencies
Related Articles:
STAT+: Trump’s FDA director pick has a history of criticizing the agency. Here are seven examples
Trump names nominees to lead CDC, FDA, and his pick for surgeon general
Patient Dies in Gene Therapy Trial, But FDA Permits Neurogene to Proceed With Low Dose
New FDA Panel Weighs In on Regulating Generative AI in Healthcare
Johns Hopkins surgeon Makary is Trump’s pick to lead FDA

Share This Article